|
[1]WANG WH, XU WH. Roles of Nrf2 and autophagy in liver fibrosis[J]. J Clin Hepatol, 2015, 31 (3) :447-451. (in Chinese) 王维昊, 许伟华.核因子E2相关因子2与细胞自噬对肝纤维化的影响[J].临床肝胆病杂志, 2015, 31 (3) :447-451.
|
|
[2]ZHU R, WANG Y, ZHANG L, et al. Oxidative Stress and liver disease[J]. Hepatol Res, 2012, 42 (8) :741-749.
|
|
[3]ELISABETTA C, TOMMASO M, ANDREA G. Pathogenesis of alcoholic liver disease:Role of oxidative metabolism[J].World J Gastroenterol, 2014, 20 (47) :17756-17772.
|
|
[4]CAI SM. The effect Angiotensin II/Angiotensin (1-7) on redox balance in liver fibrosis[D]. Guangzhou:Southern Medical University, 2014. (in Chinese) 蔡双明.血管紧张素Ⅱ/血管紧张素1-7通过调节氧化/抗氧化平衡影响肝纤维化的作用及机制[D].广州:广州南方医科大学, 2014.
|
|
[5]MOI P, CHAN K, ASUNIS I, et al. Isolation of NF-E2-related 2 (Nrf2) , a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region[J]. Proc Natl Acad Sci USA, 1994, 91 (21) :9926-9930.
|
|
[6]KOBAYASHI M, YAMAMOLO M. Nrf2-keap1-regulation of cellular defense mechanisms against electrophiles and reactive oxygen species[J]. Ade Enzyme Regul, 2006, 46:113-140.
|
|
[7]XU W, SHAO L, ZHOU C, et al. Upregulation of Nrf2 expression in non-alcoholic fatty liver and steatohepatitis[J]. Hepatogastroenterology, 2011, 58 (112) :2077-2080.
|
|
[8]LI H, DUAN HJ. Nrf2/ARE pathway and downstream antioxidant genes[J]. Chin Pharmacol bull, 2011, 27 (3) :300-303. (in Chinese) 李航, 段惠军. Nrf2/ARE信号通路及其调控的抗氧化蛋白[J].中国药理学通报, 2011, 27 (3) :300-303.
|
|
[9]KUMAR H, KIM I S, MONE SV, et al. Nature product-derived pharmacological modulators of Nre/ARE pathway for chronic disease[J]. Nat Prod Rep, 2014, 31 (1) :109-139.
|
|
[10]STEWART D, KILLEEN E, NAQUIN R, et al. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium[J]. J Biol Chem, 2003, 278:2396-2402.
|
|
[11]NGUYEN T, SHERRATTh PJ, HUANG HC, et al. Increased protein stabili-ty as a mechanism that enhances Nrf2-mediated transcriptional ac-tivation of the antioxidant response element:Degradation of Nrf2 by the 26S proteasome[J]. J Biol Chem, 2003, 278:4536-4541.
|
|
[12]ALEKSUNES LM, MANAUTOU J. Emerging role of Nrf2 in protecting againest hepatic and gastrointestinal disease[J]. Toxicol Pathol, 2007, 35 (4) :459-473.
|
|
[13]WANG YP, CHENG ML. Nrf2-keap1 antioxidant system and liver disease[J]. World Chin J Dig, 2010, 18 (18) :1907-1911. (in Chinese) 王豫萍, 程明亮. Nrf2-keap1抗氧化系统与肝脏疾病[J].世界华人消化杂志, 2010, 18 (18) :1907-1911.
|
|
[14]SCHACDLER S, KRAUSE J, HIMMCLSBACH K, et al. Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2[J]. J Biol Chem, 2010, 285 (52) :41074-41086.
|
|
[15]BENN J, SCHNEIDER RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade[J]. Proc Natl Acad Sci USA, 1994, 91 (22) :10350-10354.
|
|
[16]SEREN O, RLER G, OZLEM GULBAHAR OB. Serum levels of advanced oxidation protein products. malonyldialdehyde. and total radical trapping antioxidant parameter in patients with chronic hepatitis C[J]. Turk J Gastroenterol, 2011, 22:47-53.
|
|
[17]BURDETTE D, OLIVAREZ M, WARIS G. Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway[J]. J Gen Virol, 2010, 91 (3) :681-690.
|
|
[18]LEE JC, TSENG CK, YOUNG KC, et al. Andrographolide exerts anti-hepatitis Cvirus activity by up-regulating haeme oxygenasel via the p38 MAPA/Nrf2 pathway in human hepatoma cells[J]. Br J Pharmacol, 2014, 171:237-252.
|
|
[19]JING SUN, JINGQI FU, LU LI, et al. Nrf2 in alcoholic liver disease[J]. Toxicol Appl Pharmacol, 2018, 357:62-69.
|
|
[20]GONG P, CEDERBAUM Al. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1[J]. Hepatology, 2006, 43:144-153.
|
|
[21]WANG Z, DOU X, LI S, et al. Nuclear factor (erythroid-derived 2) -like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice[J].Hepatology, 2014, 59 (4) :1381-1392.
|
|
[22]CHOWDHRY S, NAZMY MH, MEAKIN PJ, et al. Loss of Nrf2markedly exacerbates nonalcoholic steatohepatitis[J]. Free Radic Biol Med, 2010, 48 (2) :357-371.
|
|
[23]ZENG C, ZHONG P, ZHAO Y, et al. Curcumin protects hearts from FFA-induced ingury by activating Nrf2 and inactivating NF-kB both in vitro and in vivo[J]. J Mol Cell Cardiol, 2015, 79:1-12.
|
|
[24]GOLDRING CE, KILLERINGHAM NB, ELSBY R, et al. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice[J]. Hepatalogy, 2014, 39 (5) :1267-1276.
|
|
[25]REISMAN SA, BUCKLEY DB, TANAKA Y, et al. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes[J]. Toxicol Appl Pharmacol, 2009, 236 (1) :109-114.
|
|
[26]WEERACHAYAPHORN J, MENNONE A, SOROKA CJ, et al.Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 302 (9) :g925-g936.
|
|
[27]OKAD K, SHODA J, TAGUCHI K, et al. Nrf2 counteracts cholestatic liver ingury via stimulation of hepatic defense systems[J]. Biochem Biophys Res Commun, 2009, 389 (3) :431-436.
|
|
[28]PAN PH, LIN SY, WANG YY. Protective effects of rutin on liver injury induced by biliary obstruction in rats[J]. Free Radic Biol Med, 2014, 73:106-116.
|
|
[29]DING JB, LI XH. Current perspectives on the role of autophagy in liver fibrosis[J]. J Clin Hepatol, 2013, 29 (4) :305-307. (in Chinese) 丁剑波, 李秀慧.细胞自噬在肝纤维化中的作用[J].临床肝胆病杂志, 2013, 29 (4) :305-307.
|
|
[30]FRIEDMAN SL. Hepatic stellate cells:Protean, multifunctional and enigmatic cells of the liver[J]. Physiol Rev, 2008, 88 (1) :125-172.
|
|
[31]MAJ Q, DING J, ZHANG L, et al. Protective effect of urslic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway[J]. Clin Res Hepatol Gastroenterol, 2015, 39 (2) :188-197.
|
|
[32]WANG QM, DU JL, DUAN ZJ, et al. Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation[J]. World J Gastroenterol, 2013, 19 (19) :2921-2934.
|
|
[33]XU W, HELLERBRAN C, KOHLER UA, et al. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis[J]. Lab Invest, 2008, 88 (10) :1068-1078.
|
|
[34]OH CJ, KIM JY, MIN AK, et al. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta/Smad signaling[J]. Free Radic Biol Med, 2012, 52 (3) :671-682.
|
|
[35]KAWATA K, KOBAYASHI Y, SOUDA K, et al. Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis[J]. Antioxid Redox Signal, 2010, 13 (3) :259-268.
|
|
[36]CHEN S, ZOU L, LI L, et al. The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2[J]. PLo S One, 2013, 8 (1) :e53662.
|
|
[37]BISHAYEE A, BARNES KF, BHATIA D, et al. Resveratrol suppresses oxidative stress and inflammatory response in diet hylnitrosamine initiated rat hepatoca rcinogenesis[J]. Cancer Prev Res (Phila) , 2010, 3 (6) :753-763.
|
DownLoad: